Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
08/18/2023 | Aurinia Pharmaceuticals Inc. | AUPH | Grant | Restricted Stock Units | 17.9k | $0.00 | $0 | | 08/18/2023 |
08/18/2023 | Aurinia Pharmaceuticals Inc. | AUPH | Grant | Stock Option (right to buy) | 29k | $9.49 | $274.8k | | 08/18/2023 |
06/01/2023 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Common Stock | 13.9k | $0.00 | $0 | | 06/01/2023 |
06/01/2023 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right to Buy) | 27.8k | $1.11 | $30.8k | | 06/01/2023 |
06/09/2022 | Talaris Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 14.5k | $8.45 | $122.5k | | 06/09/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | Common Stock | 54.2k | $5.60 | $303.5k | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | | 25.5k | $5.60 | $142.5k | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | Stock Option (right to buy) | 20k | $3.72 | $74.4k | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | Stock Option (right to buy) | 46.7k | $2.92 | $136.4k | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | Stock Option (right to buy) | 58.2k | $2.73 | $159k | | 05/24/2022 |
05/24/2022 | ANTARES PHARMA, INC. | ATRS | Disposition | Stock Option (right to buy) | 48.5k | $4.42 | $214.6k | | 05/24/2022 |
05/23/2022 | Quince Therapeutics, Inc. | CRTX | Grant | Employee Stock Option (right to buy) | 1.4M | $2.98 | $4.1M | | 05/19/2022 |
05/19/2022 | Quince Therapeutics, Inc. | CRTX | Grant | Common Stock | 24.3k | $0.00 | $0 | | 05/19/2022 |
05/19/2022 | Quince Therapeutics, Inc. | CRTX | Grant | Employee Stock Option (right to buy) | 151.8k | $0.55 | $83.5k | | 05/19/2022 |
05/19/2022 | Quince Therapeutics, Inc. | CRTX | Grant | Common Stock | 170.4k | $0.00 | $0 | | 05/19/2022 |
05/16/2022 | Talaris Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 29k | $6.54 | $189.7k | | 05/16/2022 |
02/25/2022 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Common Stock | 12.5k | $0.00 | $0 | | 02/25/2022 |
02/25/2022 | SANGAMO THERAPEUTICS, INC | SGMO | Grant | Stock Option (Right to Buy) | 25k | $5.90 | $147.5k | | 02/25/2022 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Other | Common Stock | 1.6k | $0.00 | $0 | | 11/19/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 10k | $35.34 | $353.4k | | 11/19/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 1.9k | $40.61 | $76.1k | | 11/19/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 3.8k | $41.64 | $156.2k | | 11/19/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 4.1k | $52.99 | $216.5k | | 11/19/2021 |
11/19/2021 | ACCELERON PHARMA INC | XLRN | Disposition | Option to Purchase Common Stock | 3.2k | $115.53 | $372.2k | | 11/19/2021 |
06/10/2021 | ANTARES PHARMA, INC. | ATRS | Grant | Stock Option (right to buy) | 48.5k | $4.42 | $214.6k | | 06/10/2021 |
06/10/2021 | ANTARES PHARMA, INC. | ATRS | Grant | Common Stock | 25.5k | $4.42 | $112.5k | | 06/10/2021 |
05/07/2021 | Emergent BioSolutions Inc. | EBS | Payment of Exercise | | 305 | $60.85 | $18.6k | | 05/07/2021 |
04/05/2021 | ACCELERON PHARMA INC | XLRN | Exercise | Option to Purchase Common Stock | 1.9k | $41.64 | $78.1k | | 04/05/2021 |
04/05/2021 | ACCELERON PHARMA INC | XLRN | Exercise | Option to Purchase Common Stock | 2k | $52.99 | $108.6k | | 04/05/2021 |
04/05/2021 | ACCELERON PHARMA INC | XLRN | Sale | Common Stock | 11.2k | $140.13 | $1.6M | | 04/05/2021 |
04/05/2021 | ACCELERON PHARMA INC | XLRN | Sale | Common Stock | 641 | $141.15 | $90.5k | | 04/05/2021 |
04/05/2021 | ACCELERON PHARMA INC | XLRN | Exercise | Option to Purchase Common Stock | 5k | $35.34 | $176.7k | | 04/05/2021 |
04/01/2021 | ACCELERON PHARMA INC | XLRN | Exercise | Option to Purchase Common Stock | 5k | $35.34 | $176.7k | | 04/01/2021 |
04/01/2021 | ACCELERON PHARMA INC | XLRN | Sale | Common Stock | 941 | $137.92 | $129.8k | | 04/01/2021 |
04/01/2021 | ACCELERON PHARMA INC | XLRN | Sale | Common Stock | 3.8k | $136.92 | $519.7k | | 04/01/2021 |
|